ChordNews
← All news

InMed Pharmaceuticals reports GAAP EPS of -$0.36

By ChordNews · First written (updated )

Comments 0

Summary

InMed Pharmaceuticals posted GAAP earnings per share of -$0.36, according to a Seeking Alpha headline published on November 3, 2026. The source item carried only a headline, so it gives no reporting period, revenue figures, or comparison to expectations or prior periods.

This continues an earlier story: BrightSpire Capital Reports Non-GAAP EPS of $0.14, In Line

Later: Mineralys Therapeutics reports GAAP loss of $0.64 per share, missing by $0.09 · Disc Medicine reports GAAP EPS of -$1.53, beating estimates by $0.20 · Allogene Therapeutics Reports GAAP EPS of -$0.15, Described as In Line · Corvus Pharmaceuticals reports GAAP EPS of -$0.22, missing by $0.02

Timeline

  1. Seeking Alpha

    Source ↗

    Reports that InMed Pharmaceuticals posted GAAP earnings per share of -$0.36.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews